tadalafil has been researched along with 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole in 1 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole) | Trials (2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole) | Recent Studies (post-2010) (2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 7 | 0 | 3 |
| Protein | Taxonomy | tadalafil (IC50) | 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole (IC50) |
|---|---|---|---|
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 10 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 10 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 10 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 4.195 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 1.725 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
1 other study(ies) available for tadalafil and 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |